These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7313067)

  • 1. [Microbial sensitivity tests with antifungal agents and their determination in body fluids].
    Vazzana A
    Quad Sclavo Diagn; 1981 Mar; 17(1):115-22. PubMed ID: 7313067
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory tests of antifungal drugs in treatment of systemic mycoses.
    Holmberg K
    Scand J Infect Dis Suppl; 1978; (16):65-73. PubMed ID: 373080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basis of antifungal chemotherapy].
    Arai T; Uno H
    Nihon Saikingaku Zasshi; 1983; 38(2):525-48. PubMed ID: 6350637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of resistance to antifungal agents].
    Makimura K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():466-70. PubMed ID: 17455664
    [No Abstract]   [Full Text] [Related]  

  • 5. N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone.
    Zaremba M; Borowski J; Feliński J; Rozkiewicz D; Rozkiewicz M; Zaremba K; Czerwiński A; Borowski E
    J Chemother; 1989 Jul; 1(4 Suppl):243-5. PubMed ID: 16312386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract]   [Full Text] [Related]  

  • 7. Basic mechanisms of antifungal chemotherapy.
    Drouhet E
    Mod Treat; 1970 May; 7(3):539-64. PubMed ID: 4920804
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifungal agents: recent developments.
    Kobayashi GS; Medoff G
    Annu Rev Microbiol; 1977; 31():291-308. PubMed ID: 334040
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D
    J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996; 14(6):384-9. PubMed ID: 8756218
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal activity of flocculosin, a novel glycolipid isolated from Pseudozyma flocculosa.
    Mimee B; Labbé C; Pelletier R; Bélanger RR
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1597-9. PubMed ID: 15793149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Has a decade of standardizing antifungal sensitivity tests accomplished anything?].
    Rodríguez Tudela JL; Cuenca Estrella M
    Enferm Infecc Microbiol Clin; 2002 May; 20(5):191-3. PubMed ID: 12006254
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The resistance of opportunistic fungi to antifungals].
    Rodríguez Tudela JL
    Rev Clin Esp; 1997 Apr; 197 Suppl 1():67-74. PubMed ID: 9297209
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
    Vitale RG; Afeltra J; de Hoog GS; Rijs AJ; Verweij PE
    J Antimicrob Chemother; 2003 May; 51(5):1297-300. PubMed ID: 12697648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
    Schwarz P; Janbon G; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2007 Jan; 51(1):383-5. PubMed ID: 17043122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal resistance in pathogenic fungi.
    Perea S; Patterson TF
    Clin Infect Dis; 2002 Nov; 35(9):1073-80. PubMed ID: 12384841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
    Duggineni S; Srivastava G; Kundu B; Kumar M; Chaturvedi AK; Shukla PK
    Int J Antimicrob Agents; 2007 Jan; 29(1):73-8. PubMed ID: 17156978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing of medically important fungi.
    Merz WG
    Adv Exp Med Biol; 1986; 202():127-34. PubMed ID: 3788693
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status of studies on sensitivity to antifungal agents].
    Martín Mazuelos E
    Enferm Infecc Microbiol Clin; 1992; 10(6):366-71. PubMed ID: 1391021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.